Cancer Research Cancer Research Funding Available Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chlenski, A.
Right arrow Articles by Cohn, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chlenski, A.
Right arrow Articles by Cohn, S. L.
[Cancer Research 62, 7357-7363, December 15, 2002]
© 2002 American Association for Cancer Research

Tumor Biology

SPARC Is a Key Schwannian-derived Inhibitor Controlling Neuroblastoma Tumor Angiogenesis1

Alexandre Chlenski, Shuqing Liu, Susan E. Crawford, Olga V. Volpert, George H. DeVries, Amy Evangelista, Qiwei Yang, Helen R. Salwen, Robert Farrer, James Bray and Susan L. Cohn2

Departments of Pediatrics [S. L. C.] and Pathology [S. E. C.] and The Robert H. Lurie Comprehensive Cancer Center [A. C., S. L., O. V. V., A. E., Q. Y., H. R. S., J. B.], Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, and the Department of Cell Biology, Neurobiology, and Anatomy, Loyola University of Chicago Stritch School of Medicine, Chicago, Illinois 60153 [G. H. D., R. F.]

Neuroblastoma (NB), a common pediatric neoplasm, consists of two main cell populations: neuroblastic/ganglionic cells and Schwann cells. NB tumors with abundant Schwannian stroma display a more benign clinical behavior than stroma-poor tumors. Recent studies suggest that Schwann cells influence NB tumor growth via secreted factors that induce differentiation, suppress proliferation, and inhibit angiogenesis. Two angiogenesis inhibitors, pigment epithelium-derived factor and tissue inhibitor of metalloproteinase-2, have been detected in Schwann cell secretions. Here, we isolated another Schwann cell-derived secreted inhibitor of angiogenesis, a 43-kDa protein identified as SPARC (secreted protein acidic and rich in cysteine), an extracellular matrix protein. We found SPARC to be critical for the antiangiogenic phenotype of cultured Schwann cells. We also show that purified SPARC potently inhibits angiogenesis and significantly impairs NB tumor growth in vivo. SPARC may be an effective candidate for the treatment of children with clinically aggressive, Schwannian stroma-poor NB tumors.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
C. Faye, E. Chautard, B. R. Olsen, and S. Ricard-Blum
The First Draft of the Endostatin Interaction Network
J. Biol. Chem., August 14, 2009; 284(33): 22041 - 22047.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
M.-R. Pan, H.-C. Chang, L.-Y. Chuang, and W.-C. Hung
The Nonsteroidal Anti-Inflammatory Drug NS398 Reactivates SPARC Expression via Promoter Demethylation to Attenuate Invasiveness of Lung Cancer Cells
Experimental Biology and Medicine, April 1, 2008; 233(4): 456 - 462.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
N. Said, M. J. Socha, J. J. Olearczyk, A. A. Elmarakby, J. D. Imig, and K. Motamed
Normalization of the Ovarian Cancer Microenvironment by SPARC
Mol. Cancer Res., October 1, 2007; 5(10): 1015 - 1030.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Peddinti, R. Zeine, D. Luca, R. Seshadri, A. Chlenski, K. Cole, B. Pawel, H. R. Salwen, J. M. Maris, and S. L. Cohn
Prominent Microvascular Proliferation in Clinically Aggressive Neuroblastoma
Clin. Cancer Res., June 15, 2007; 13(12): 3499 - 3506.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Q. Yang, Y. Tian, S. Liu, R. Zeine, A. Chlenski, H. R. Salwen, J. Henkin, and S. L. Cohn
Thrombospondin-1 Peptide ABT-510 Combined with Valproic Acid Is an Effective Antiangiogenesis Strategy in Neuroblastoma
Cancer Res., February 15, 2007; 67(4): 1716 - 1724.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
F. Taghizadeh, M. J. Tang, and I. T. Tai
Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy
Mol. Cancer Ther., January 1, 2007; 6(1): 309 - 317.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Kzhyshkowska, G. Workman, M. Cardo-Vila, W. Arap, R. Pasqualini, A. Gratchev, L. Krusell, S. Goerdt, and E. H. Sage
Novel Function of Alternatively Activated Macrophages: Stabilin-1-Mediated Clearance of SPARC
J. Immunol., May 15, 2006; 176(10): 5825 - 5832.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. E. Koblinski, B. R. Kaplan-Singer, S. J. VanOsdol, M. Wu, J. A. Engbring, S. Wang, C. M. Goldsmith, J. T. Piper, J. G. Vostal, J. F. Harms, et al.
Endogenous Osteonectin/SPARC/BM-40 Expression Inhibits MDA-MB-231 Breast Cancer Cell Metastasis
Cancer Res., August 15, 2005; 65(16): 7370 - 7377.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Jodele, C. F. Chantrain, L. Blavier, C. Lutzko, G. M. Crooks, H. Shimada, L. M. Coussens, and Y. A. DeClerck
The Contribution of Bone Marrow-Derived Cells to the Tumor Vasculature in Neuroblastoma Is Matrix Metalloproteinase-9 Dependent
Cancer Res., April 15, 2005; 65(8): 3200 - 3208.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Liu, Y. Tian, A. Chlenski, Q. Yang, P. Zage, H. R. Salwen, S. E. Crawford, and S. L. Cohn
Cross-Talk between Schwann Cells and Neuroblasts Influences the Biology of Neuroblastoma Xenografts
Am. J. Pathol., March 1, 2005; 166(3): 891 - 900.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Chlenski, S. Liu, L. J. Baker, Q. Yang, Y. Tian, H. R. Salwen, and S. L. Cohn
Neuroblastoma Angiogenesis Is Inhibited with a Folded Synthetic Molecule Corresponding to the Epidermal Growth Factor-Like Module of the Follistatin Domain of SPARC
Cancer Res., October 15, 2004; 64(20): 7420 - 7425.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Q. Yang, S. Liu, Y. Tian, C. Hasan, D. Kersey, H. R. Salwen, A. Chlenski, E. J. Perlman, and S. L. Cohn
Methylation-Associated Silencing of the Heat Shock Protein 47 Gene in Human Neuroblastoma
Cancer Res., July 1, 2004; 64(13): 4531 - 4538.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
P. A. Puolakkainen, R. A. Brekken, S. Muneer, and E. H. Sage
Enhanced Growth of Pancreatic Tumors in SPARC-Null Mice Is Associated With Decreased Deposition of Extracellular Matrix and Reduced Tumor Cell Apoptosis
Mol. Cancer Res., April 1, 2004; 2(4): 215 - 224.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Q.-W. Yang, S. Liu, Y. Tian, H. R. Salwen, A. Chlenski, J. Weinstein, and S. L. Cohn
Methylation-associated Silencing of the Thrombospondin-1 Gene in Human Neuroblastoma
Cancer Res., October 1, 2003; 63(19): 6299 - 6310.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Yi, T. Sakai, R. Fassler, and E. Ruoslahti
Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity
PNAS, September 30, 2003; 100(20): 11435 - 11438.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Agathanggelou, I. Bieche, J. Ahmed-Choudhury, B. Nicke, R. Dammann, S. Baksh, B. Gao, J. D. Minna, J. Downward, E. R. Maher, et al.
Identification of Novel Gene Expression Targets for the Ras Association Domain Family 1 (RASSF1A) Tumor Suppressor Gene in Non-Small Cell Lung Cancer and Neuroblastoma
Cancer Res., September 1, 2003; 63(17): 5344 - 5351.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.